The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Ventilator-associated pneumonia in the ICU
Open accessAbstract
Ventilator-associated pneumonia (VAP) is defined as pneumonia that occurs 48-72 hours or thereafter follow¬ing endotracheal intubation, characterized by the pre¬sence of a new or progressive infiltrate, signs of systemic infection (fever, altered white blood cell count), changes in sputum characteristics, and detection of a causative agent [ 1 ]. VAP contributes to approximately half of all cases of hospital-acquired pneumonia [ 1 ], [ 2 ]. VAP is estimated to occur in 9-27 % of all mechanically ventilated patients, with the highest risk being early in the course of hospitalization [ 1 ], [ 3 ]. It is the second most common nosocomial infection in the intensive care unit (ICU) and the most common in mechanically ventilated patients [ 4 ], [ 5 ]. VAP rates range from 1.2 to 8.5 per 1,000 ventilator days and are reliant on the definition used for diagnosis [ 6 ]. Risk for VAP is greatest during the first 5 days of mechanical ventilation (3 %) with the mean duration between intubation and development of VAP being 3.3 days [ 1 ], [ 7 ]. This risk declines to 2 %/day between days 5 to 10 of ventilation, and 1 %/day thereafter [ 1 ], [ 8 ]. Earlier studies placed the attributable mortality for VAP at between 33-50 %, but this rate is variable and relies heavily on the underlying medical illness [ 1 ]. Over the years, the attributable risk of death has decreased and is more recently estimated at 9-13 % [ 9 ], [ 10 ], largely because of implementation of preventive strategies. Approximately 50 % of all antibiotics adminis¬tered in ICUs are for treatment of VAP [ 2 ], [ 4 ]. Early onset VAP is defined as pneumonia that occurs within 4 days and this is usually attributed to antibiotic sensitive pathogens whereas late onset VAP is more likely caused by multidrug resistant (MDR) bacteria and emerges after 4 days of intubation [ 1 ], [ 4 ]. Thus, VAP poses grave implications in endotracheally intubated adult patients in ICUs worldwide and leads to increased adverse outcomes and healthcare costs. Independent risk factors for development of VAP are male sex, admission for trauma and intermediate underlying disease severity, with odds ratios (OR) of 1.58, 1.75 and 1.47-1.70, respectively [ 7 ].
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-644st · Cited by 5,877
Ventilator-associated Pneumonia
Chastre, J., & Fagon, J.-Y. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.7.2105078 · Cited by 2,812
Vincent, J.-L. (1995) · JAMA · doi:10.1001/jama.1995.03530080055041 · Cited by 1,632
Chastre, J., Wolff, M., Fagon, J.-Y., Chevret, S., Thomas, F., Wermert, D., Clementi, E., Gonzalez, J., Jusserand, D., Asfar, P., et al. (2003) · JAMA · doi:10.1001/jama.290.19.2588 · Cited by 1,376
Epidemiology and Outcomes of Ventilator-Associated Pneumonia in a Large US Database
Rello, J., Ollendorf, D. A., Oster, G., Vera-Llonch, M., Bellm, L., Redman, R., & Kollef, M. H. (2002) · Chest · doi:10.1378/chest.122.6.2115 · Cited by 1,306
Pugin, J., Auckenthaler, R., Mili, N., Janssens, J.-P., Lew, P. D., & Suter, P. M. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/143.5_pt_1.1121 · Cited by 1,132
Incidence of and Risk Factors for Ventilator-Associated Pneumonia in Critically Ill Patients
Cook, D. J., Walter, S. D., Cook, R. J., Griffith, L. E., Guyatt, G. H., Leasa, D., Jaeschke, R. Z., & Brun-Buisson, C. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-6-199809150-00002 · Cited by 1,113
JOHANSON, W. G., PIERCE, A. K., SANFORD, J. P., & THOMAS, G. D. (1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-77-5-701 · Cited by 1,087
SINGH, N., ROGERS, P., ATWOOD, C. W., WAGENER, M. M., & YU, V. L. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.2.9909095 · Cited by 1,032
Impact of BAL Data on the Therapy and Outcome of Ventilator-Associated Pneumonia
Luna, C. M., Vujacich, P., Niederman, M. S., Vay, C., Gherardi, C., Matera, J., & Jolly, E. C. (1997) · Chest · doi:10.1378/chest.111.3.676 · Cited by 916
Cited by
Health care-associated infections – an overview
Haque, M., Sartelli, M., McKimm, J., & Abu Bakar, M. B. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s177247 · Cited by 1,200
Colonization, Infection, and the Accessory Genome of Klebsiella pneumoniae
Martin, R. M., & Bachman, M. A. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00004 · Cited by 1,058
Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU-VAP/CAP study
Koulenti, D., Tsigou, E., & Rello, J. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2703-z · Cited by 392
Past and Present ARDS Mortality Rates: A Systematic Review
Máca, J., Jor, O., Holub, M., Sklienka, P., Burša, F., Burda, M., Janout, V., & Ševčík, P. (2017) · Respiratory Care · doi:10.4187/respcare.04716 · Cited by 315
Antimicrobial and Antifouling Strategies for Polymeric Medical Devices
Zander, Z. K., & Becker, M. L. (2018) · ACS Macro Letters · doi:10.1021/acsmacrolett.7b00879 · Cited by 310
Metadata
- Authors
- Kalanuria, A. A., Zai, W., & Mirski, M.
- Venue
- Critical Care
- Published
- 2014-03-18
- Volume
- 18
- Issue
- 2
- Pages
- 208-208
- ISSN
- 1364-8535 (ISSN-L)
- OpenAlex
- W2153850990
- Cited by
- 550
- References
- 47
- FWCI
- 24.28
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ventilator-associated pneumonia in the ICU. https://app.cochat.ai/papers/10.1186/cc13775
- The paper
- Kalanuria, A. A., Zai, W., & Mirski, M. (2014). Ventilator-associated pneumonia in the ICU. Critical Care. https://doi.org/10.1186/cc13775
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.